Biohackers take aim at big pharma’s stranglehold on insulin

Re:Biohackers take aim at big pharma’s stranglehold on insulin by sithlord on Monday June 28, 2021 @02:21PM (#27665572)

This is probably true - and I am not here to point fingers - but I will say that the insulin manufacturers are at some fault too, they do just enough to keep renewing their rights to their insulins every time they come around.

[ Parent | on HN ]

Re:Biohackers take aim at big pharma’s stranglehold on insulin by lotsofpulp on Monday June 28, 2021 @02:37PM (#27665818)

You cannot renew a patent in the US. They get a new product patented, but anyone is still free to come along and make the older one. However, I bet there is a ton of expertise and cost required with doing that, and that is what is stopping others.

[ Parent | on HN ]

Re:Biohackers take aim at big pharma’s stranglehold on insulin by sithlord on Monday June 28, 2021 @04:05PM (#27667177)

they "renew" by "improving" their existing product enough to make it obsolete, and to get a new patent. Per the article below this has been happening since 1923

https://www.hopkinsmedicine.org/news/media/releases/why_peop...

[ Parent | on HN ]

Re:Biohackers take aim at big pharma’s stranglehold on insulin by lotsofpulp on Monday June 28, 2021 @05:28PM (#27668404)

That is better described as a new patent. The product for the patent that expired is expired, and can be made by others.

[ Parent | on HN ]